The U.S. Food and Drug Administration approved British drugmaker GSK's combination vaccine to protect against meningococcal ...

Ronald E. Blaylock, a director at Pfizer Inc. (NYSE:PFE), purchased 19,457 shares of the company's common stock. The ...

Pfizer clinches the top spot in the competitive 2025 Super Bowl ad race, promising groundbreaking visibility during the big ...

Jasper Therapeutics (JSPR – Research Report) received a Buy rating and a $38.00 price target from UBS analyst Trung Huynh today. The company’s ...

Shareholders of Pfizer may learn more about this investigation by contacting Berger Montague: Radha Raghavan at [email protected] or (332) 271-8908, or Andrew Abramowitz at [email protected] or (215) ...

All this negativity, however, does open up an opportunity for investors to buy the stock at a discount. Despite being a top ...

Pfizer announced Jeffrey Legos, PhD, MBA as its new chief oncology officer. Bluejay Therapeutics announced Mary Cromwell, PhD, has joined its leadership team as SVP and head of technical operations.

Pfizer Inc. closed 19.06% short of its 52-week high of $31.54, which the company reached on July 30th.

Super Bowl LIX has now ended with the Philadelphia Eagles winning it all. However, they weren't the only winners as we were ...

This year's Super Bowl commercials are going for laughs, with advertisers betting that viewers need a diversion from weighty ...